Free Trial

HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Pathstone Holdings LLC

HCA Healthcare logo with Medical background

Pathstone Holdings LLC increased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 23.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 27,589 shares of the company's stock after acquiring an additional 5,175 shares during the period. Pathstone Holdings LLC's holdings in HCA Healthcare were worth $11,213,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of HCA. MFA Wealth Advisors LLC bought a new position in HCA Healthcare during the second quarter valued at approximately $27,000. Unique Wealth Strategies LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth approximately $28,000. Bangor Savings Bank raised its holdings in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company's stock worth $27,000 after buying an additional 45 shares during the period. GPS Wealth Strategies Group LLC raised its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock worth $31,000 after buying an additional 71 shares during the period. Finally, Capital Performance Advisors LLP purchased a new position in HCA Healthcare during the 3rd quarter worth $41,000. Institutional investors own 62.73% of the company's stock.

Insiders Place Their Bets

In other news, EVP Michael S. Cuffe sold 8,358 shares of the business's stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 21.97 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the business's stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 15,155 shares of company stock worth $5,608,990. Corporate insiders own 1.60% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Truist Financial raised their price objective on HCA Healthcare from $390.00 to $430.00 and gave the stock a "buy" rating in a report on Monday, August 19th. StockNews.com downgraded HCA Healthcare from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Oppenheimer raised their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research report on Monday, October 28th. Finally, UBS Group raised their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a "buy" rating in a research report on Wednesday, August 14th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $385.00.

Check Out Our Latest Report on HCA

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $333.00 on Thursday. HCA Healthcare, Inc. has a twelve month low of $245.84 and a twelve month high of $417.14. The business has a 50-day moving average price of $381.99 and a 200 day moving average price of $358.12. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market cap of $84.35 billion, a PE ratio of 14.95, a P/E/G ratio of 1.29 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.79%. HCA Healthcare's dividend payout ratio (DPR) is currently 11.85%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Should you invest $1,000 in HCA Healthcare right now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines